Kevin Koch

CIK: 0001185829

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)8 (42.1%)

Position reduction

Option Exercises (M)7 (36.8%)

Derivative conversions

Awards (A)4 (21.1%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

EWTX

Edgewise Therapeutics, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (19 total)

EWTX
Edgewise Therapeutics, Inc.
Aug 12, 2026
Award(A)
Stock Option (Right to Buy)
Direct
200K shares-
EWTX
Edgewise Therapeutics, Inc.
Aug 12, 2026
Exercise(M)
Direct
21.9K shares-
EWTX
Edgewise Therapeutics, Inc.
Aug 12, 2026
Sale(S)
Direct
8.8K shares at avg. $43.64$383K
EWTX
Edgewise Therapeutics, Inc.
Aug 12, 2026
Sale(S)
Direct
8.3K shares at avg. $43.66$361K
EWTX
Edgewise Therapeutics, Inc.
Aug 12, 2026
Sale(S)
Direct
913 shares at avg. $44.33$40K
EWTX
Edgewise Therapeutics, Inc.
Aug 12, 2026
Award(A)
Restricted Stock Units
Direct
100K shares-
EWTX
Edgewise Therapeutics, Inc.
Aug 12, 2026
Exercise(M)
Direct
18K shares-
EWTX
Edgewise Therapeutics, Inc.
Aug 12, 2025
Award(A)
Stock Option (Right to Buy)
Direct
525K shares-
EWTX
Edgewise Therapeutics, Inc.
Aug 12, 2025
Exercise(M)
Direct
18K shares-
EWTX
Edgewise Therapeutics, Inc.
Aug 12, 2025
Sale(S)
Direct
8K shares at avg. $13.39$107K
EWTX
Edgewise Therapeutics, Inc.
Aug 12, 2025
Award(A)
Restricted Stock Units
Direct
87.5K shares-
EWTX
Edgewise Therapeutics, Inc.
May 2, 2025
Sale(S)
Direct
4.3K shares at avg. $16.45$70K
EWTX
Edgewise Therapeutics, Inc.
May 1, 2025
Exercise(M)
Direct
10.4K shares-
EWTX
Edgewise Therapeutics, Inc.
Mar 7, 2025
Exercise(M)
Direct
100 shares at avg. $0.18$18
EWTX
Edgewise Therapeutics, Inc.
Mar 7, 2025
Sale(S)
Direct
100 shares at avg. $30.00$3K
EWTX
Edgewise Therapeutics, Inc.
Feb 6, 2025
Exercise(M)
Direct
900 shares at avg. $13.11$12K
EWTX
Edgewise Therapeutics, Inc.
Feb 6, 2025
Sale(S)
Direct
900 shares at avg. $31.13$28K
EWTX
Edgewise Therapeutics, Inc.
Feb 5, 2025
Sale(S)
Direct
8.6K shares at avg. $30.03$259K
EWTX
Edgewise Therapeutics, Inc.
Feb 5, 2025
Exercise(M)
Direct
8.6K shares at avg. $0.18$2K

		Type	Shares	Price		Ownership
Aug 12, 2026	EWTX Edgewise Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	200,000	-	-	Direct
Aug 12, 2026	EWTX Edgewise Therapeutics, Inc.	Exercise(M)	21,875	-	$0	Direct
Aug 12, 2026	EWTX Edgewise Therapeutics, Inc.	Sale(S)	8,782	$43.64	$383,254	Direct
Aug 12, 2026	EWTX Edgewise Therapeutics, Inc.	Sale(S)	8,276	$43.66	$361,315	Direct
Aug 12, 2026	EWTX Edgewise Therapeutics, Inc.	Sale(S)	913	$44.33	$40,473	Direct
Aug 12, 2026	EWTX Edgewise Therapeutics, Inc.	Award(A) Restricted Stock Units	100,000	-	-	Direct
Aug 12, 2026	EWTX Edgewise Therapeutics, Inc.	Exercise(M)	17,969	-	$0	Direct
Aug 12, 2025	EWTX Edgewise Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	525,000	-	-	Direct
Aug 12, 2025	EWTX Edgewise Therapeutics, Inc.	Exercise(M)	17,968	-	-	Direct
Aug 12, 2025	EWTX Edgewise Therapeutics, Inc.	Sale(S)	7,972	$13.39	$106,764	Direct
Aug 12, 2025	EWTX Edgewise Therapeutics, Inc.	Award(A) Restricted Stock Units	87,500	-	-	Direct
May 2, 2025	EWTX Edgewise Therapeutics, Inc.	Sale(S)	4,276	$16.45	$70,358	Direct
May 1, 2025	EWTX Edgewise Therapeutics, Inc.	Exercise(M)	10,417	-	-	Direct
Mar 7, 2025	EWTX Edgewise Therapeutics, Inc.	Exercise(M)	100	$0.18	$18	Direct
Mar 7, 2025	EWTX Edgewise Therapeutics, Inc.	Sale(S)	100	$30.00	$3,000	Direct
Feb 6, 2025	EWTX Edgewise Therapeutics, Inc.	Exercise(M)	900	$13.11	$11,799	Direct
Feb 6, 2025	EWTX Edgewise Therapeutics, Inc.	Sale(S)	900	$31.13	$28,018	Direct
Feb 5, 2025	EWTX Edgewise Therapeutics, Inc.	Sale(S)	8,636	$30.03	$259,298	Direct
Feb 5, 2025	EWTX Edgewise Therapeutics, Inc.	Exercise(M)	8,636	$0.18	$1,554	Direct

1-19 of 19 transactions

About KOCH KEVIN

KOCH KEVIN (SEC CIK 0001185829) files insider reports with the SEC as President and CEO of Edgewise Therapeutics, Inc. (EWTX).

Signal8 holds 5 ownership filings by KOCH KEVIN, all Form 4s, filed between Feb 7, 2025 and Aug 14, 2026. Those filings report 19 transactions, from Feb 5, 2025 to Aug 12, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on KOCH KEVIN's filings is in BOULDER, CO.

Recent filings by KOCH KEVIN

Aug 12, 2026: Grant or award of EWTX derivative securities (Form 4, code A).
Aug 12, 2026: Option exercise of EWTX shares (Form 4, code M).
Aug 12, 2026: Open-market sales of EWTX shares (3 lines, Form 4, code S).
Aug 12, 2026: Grant or award of EWTX derivative securities (Form 4, code A).
Aug 12, 2026: Option exercise of EWTX shares (Form 4, code M).

Other insiders filing for Edgewise Therapeutics, Inc. (EWTX)

Fox Jonathan C, Director
Nofi Michael, Chief Financial Officer
Donovan Joanne M., CMO
Russell Alan J, Chief Scientific Officer
MOORE JOHN R, General Counsel
Derakhshan Behrad, Chief Business Officer

How to read Form 4 transaction codes